ABLYNX Aktie

2,75 EUR -0,5425%

Zu Ihrem Onlinebroker

kaufen verkaufen

ABLYNX Aktienkurs : 23.05. ( 15 Min. verzögert)
2,75 € Letzter Kurs	-0,54% Veränderung	2,77 € Vortag	2,75 € Eröffnungskurs

Realtime:

2,75

-0,54%

mehr Informationen

Hoch/Tief		Volumen		Geldkurs	Briefkurs
2,75 - 2,75 Tag	8,65 - 2,22 52 Wochen	0 Tag	47 Ø 52 Wochen	0,0000000 0 Stücke	0,0000000 0 Stücke

ABLYNX Aktienkurs

Wollen Sie wissen, wie es mit dieser Aktie weitergeht?
Wir informieren Sie kostenlos.

Erhalten Sie außerdem Expertenanalysen von:
Gevestor Täglich und John Gossens Daily DAX

20.05.

Ablynx revenues increase 159%

Ablynx, the Belgian-based biopharmaceutical company focused on the discovery and development of Nanobodies® for the treatment of serious life-threatening diseases, announced increased revenues by 159…
17.05.

European Stocks Seen Largely Unchanged

Ablynx narrowed its first-quarter net loss to EUR 6.2 million from EUR 13.8 million in the prior year quarter, helped by lower R&D expenses as a result of re-focusing of resources within the prod…

16.05.

ABLYNX ANNOUNCES Q1 2012 BUSINESS UPDATE

REGULATED INFORMATION GHENT, Belgium, 16 th May 2012 - Ablynx [Euronext Brussels: ABLX], the Belgian-based biopharmaceutical company focused on the discovery and development of NanobodiesR for the treatment of serious...
16.05.

Market Preview - 16 May 2012; Eyes on the FOMC minutes

Compagnie Financiere Richemont SA, Ablynx NV, Lamda Development SA, Maternus Kliniken AG and Sloman Neptun Schiffahrts AG are scheduled to announce their results today. Siemens...
11.05.

RXi Pharmaceuticals Appoints Industry Veteran Dr. Geert Cauwenbergh as ...

He is a member of the board of directors of Ablynx NV and Euroscreen SA, both European biotechnology companies. In 2005, Dr. Cauwenbergh was inducted into the New Jersey High-Tech Hall...